:: SIHL ::

Company Profile

Smart Quotes

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE2940.1035.65 (+1.23 %)

PREV CLOSE ( ) 2904.45

OPEN PRICE ( ) 2917.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16334

TODAY'S LOW / HIGH ( )2884.75 3045.00

52 WK LOW / HIGH ( )1924.3 3147.45

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924

Management Info

R S Karnad - Chairman Bhushan Akshikar - Managing Director

Registered Office

Address Gsk House, Dr. Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com / in.investorquery@gsk.com

Website www.gsk-india.com

Registrar's Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

25Apr GlaxoSmithKline Pharmaceuticals inform
In reference to email dated April 24, 2025 regarding clarification for s..

09Apr GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..

31Mar GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requ..

28Mar GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of..

26Mar Appointment of Director
Inter alia, approved: 1. Appointment of Independent Directors: Purs..

Financials

in Crores

	QTR Dec 24	ANNUAL 24
Net Profit	228.58	584.69
Gross Profit	306.35	809.04
Operating Profit	325.24	1024.13
Net Sales	946.36	3407.25

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE) 5124.50 (1.86%)	M.Cap ( in Cr)61177.82
AMI Organics (BSE) 1136.00 (4.27%)	M.Cap ( in Cr)9267.56
Sun Pharma Inds. (BSE) 1830.20 (1.41%)	M.Cap ( in Cr)439990.05
Blue Jet Healthcare (BSE) 711.75 (3.65%)	M.Cap ( in Cr)12349.00
Lupin (BSE) 2088.35 (1.01%)	M.Cap ( in Cr)95343.82

Shareholding Pattern

	PROMOTERS	75%
	NON-INSTITUTION	12.69%
	MUTUAL FUNDS/UTI	5.17%
	FI/BANKS/INSURANCE	2.6%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma Fund(G)	3.61
Aditya Birla SL MNC Fund-Reg(G)	3.39
UTI Nifty Midcap 150 Quality 50 Index Fund-Reg(G)	2.53
DSP Nifty Midcap 150 Quality 50 ETF	2.52
DSP Nifty Midcap 150 Quality 50 Index Fund-Reg(G)	2.52
SBI Magnum Midcap Fund-Reg(G)	2.34
ICICI Pru Quant Fund(G)	2.21

SIHL House, Opp.Ambawadi Jain Temple, Nehrunagar Cross Roads, Ahmedabad-380015

Prevent Unauthorised transactions in your account. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge as well as for mobile no and for email id updation.Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors".

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NO

SEBI Regn.no. INZ000167335 Member Code: NSE-07590 BSE Sebi Regn. 943 AMFI ARN- 39843 SEBI Registration No. (DP)- IN-DP-465-2020 NSDL:IN-DP-NSDL-34-97,DP ID:IN300343 CDSL:IN-DP-CSDL-199-2003,DP ID:12029300 Approved person Registration no. with NSDL Database Management Limited(NDML) :IRDA/IR1/2013/004Approved person Registration no. with Center Insurance Repository Limited (CIR): IRDA/IR2/2013/123

REGISTERED ADDRESS:

810, X-Change Plaza, DSCCSL (53E), Road 5E, Block 53, Zone 5, Gift City, Gandhinagar 382050

SHAH INVESTOR'S HOME LTD. CIN NO:-U67120GJ1994PLC023257 SIHL COMMODITIES LTD. CIN NO:-U45201GJ1995PLC025825SIHL CONSULTANCY LTD. CIN NO:-U74140GJ2006PLC049662 SIHL FINCAP LTD.CIN NO:-U65923GJ2006PLC049661 SIHL GLOBAL INVESTMENTS (IFSC) PVT. LTD. CIN NO:-U67190GJ2016PTC094444NSEL MemberCode :10560

CORRESPONDENCE ADDRESS:

SIHL House, Opp. Ambawadi Jain Temple, Nehrunagar Cross Road, Ahmedabad-380015.

For any complains email us at investors@sihl.in Shah Investor's Home Ltd. Member: